For: | Zhang CG, Zhang B, Deng WS, Duan M, Chen W, Wu ZY. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis. World J Gastroenterol 2016; 22(18): 4484-4500 [PMID: 27182159 DOI: 10.3748/wjg.v22.i18.4484] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i18/4484.htm |
Number | Citing Articles |
1 |
Linlin Xu, Yuan Yuan, Zhaodi Che, Xiaozhi Tan, Bin Wu, Cunchuan Wang, Chengfang Xu, Jia Xiao. The Hepatoprotective and Hepatotoxic Roles of Sex and Sex-Related Hormones. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.939631
|
2 |
Hui-Dong Liu, Shao-Wei Wang. Role of noncoding RNA in the pathophysiology and treatment of intrauterine adhesion. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.948628
|
3 |
Wensheng Deng, Yiming Zhu, Jiayun Lin, Lei Zheng, Chihao Zhang, Meng Luo. Inhibition of soluble epoxide hydrolase lowers portal hypertension in cirrhotic rats by ameliorating endothelial dysfunction and liver fibrosis. Prostaglandins & Other Lipid Mediators 2017; 131: 67 doi: 10.1016/j.prostaglandins.2017.08.004
|
4 |
Qian Xu, Hua Duan, Lu Gan, Xin Liu, Fang Chen, Xue Shen, Yi-Qun Tang, Sha Wang. MicroRNA-1291 promotes endometrial fibrosis by regulating the ArhGAP29-RhoA/ROCK1 signaling pathway in a murine model. Molecular Medicine Reports 2017; 16(4): 4501 doi: 10.3892/mmr.2017.7210
|
5 |
Patrik Mik, Katsiaryna Barannikava, Polina Surkova. Biased Quantification of Rat Liver Fibrosis—Meta-Analysis with Practical Recommendations and Clinical Implications. Journal of Clinical Medicine 2023; 12(15): 5072 doi: 10.3390/jcm12155072
|
6 |
Sergi Guixé-Muntet, Chang-Peng Zhu, Wei-Fen Xie, Jordi Gracia-Sancho. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease. Pharmacology & Therapeutics 2020; 215: 107626 doi: 10.1016/j.pharmthera.2020.107626
|
7 |
Marina Vilaseca, Sergi Guixé-Muntet, Anabel Fernández-Iglesias, Jordi Gracia-Sancho. Advances in therapeutic options for portal hypertension. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818811294
|
8 |
Wei Chen, Wang Peng, Ronghua Wang, Shuya Bai, Mengdie Cao, Si Xiong, Yanling Li, Yilei Yang, Jingwen Liang, Luyao Liu, Hamza O. Yazdani, Yuchong Zhao, Bin Cheng. Exosome-derived tRNA fragments tRF-GluCTC-0005 promotes pancreatic cancer liver metastasis by activating hepatic stellate cells. Cell Death & Disease 2024; 15(1) doi: 10.1038/s41419-024-06482-3
|
9 |
Türkan Koyuncuoğlu, Alper Yıldırım, Ekin K. Dertsiz, Meral Yüksel, Feriha Ercan, Berrak Ç. Yeğen. Estrogen receptor agonists protect against acetaminophen-induced hepatorenal toxicity in rats. Life Sciences 2020; 263: 118561 doi: 10.1016/j.lfs.2020.118561
|
10 |
Yaxin Wang, Canyan Wu, Jiahui Zhou, Haiming Fang, Jiajia Wang. Overexpression of estrogen receptor β inhibits cellular functions of human hepatic stellate cells and promotes the anti-fibrosis effect of calycosin via inhibiting STAT3 phosphorylation. BMC Pharmacology and Toxicology 2022; 23(1) doi: 10.1186/s40360-022-00617-y
|
11 |
Kehui Zhang, Liubing Lin, Yingying Zhu, Na Zhang, Meng’en Zhou, Yong Li. Saikosaponin d Alleviates Liver Fibrosis by Negatively Regulating the ROS/NLRP3 Inflammasome Through Activating the ERβ Pathway. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.894981
|
12 |
Bo Yoon Chang, Dae Sung Kim, Hye Soo Kim, Sung Yeon Kim. Evaluation of estrogenic potential by herbal formula, HPC 03 for in vitro and in vivo. Reproduction 2018; 155(2): 103 doi: 10.1530/REP-17-0530
|
13 |
Bin Zhang, Cheng‐Gang Zhang, Lin‐Hua Ji, Gang Zhao, Zhi‐Yong Wu. Estrogen receptor β selective agonist ameliorates liver cirrhosis in rats by inhibiting the activation and proliferation of hepatic stellate cells. Journal of Gastroenterology and Hepatology 2018; 33(3): 747 doi: 10.1111/jgh.13976
|
14 |
Jie-Qiong Ma, Yu-Jia Zhang, Zhi-Kai Tian. Anti-oxidant, anti-inflammatory and anti-fibrosis effects of ganoderic acid A on carbon tetrachloride induced nephrotoxicity by regulating the Trx/TrxR and JAK/ROCK pathway. Chemico-Biological Interactions 2021; 344: 109529 doi: 10.1016/j.cbi.2021.109529
|
15 |
David Montefusco, Maryam Jamil, Melissa A. Maczis, William Schroeder, Moshe Levi, Suman Ranjit, Jeremy Allegood, Dipankar Bandyopadhyay, Reuben Retnam, Sarah Spiegel, L. Ashley Cowart. Sphingosine kinase 1 mediates sexual dimorphism in fibrosis in a mouse model of NASH. Molecular Metabolism 2022; 62: 101523 doi: 10.1016/j.molmet.2022.101523
|